THC
Tenet Healthcare CorporationNYSEHealthcare$188.17-1.10%ClosedMarket Cap: $16.54B
As of 2026-04-06
Valuation
P/E (TTM)
11.75
PEG
—
P/B
3.92
P/S
0.78
EV/EBITDA
6.01
DCF Value
$352.28
FCF Yield
15.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.9%
Operating Margin
16.5%
Net Margin
6.6%
ROE
34.8%
ROA
8.2%
ROIC
11.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.53B | 41.5% | $853.0M | $371.0M | $4.22 | — |
| FY 2025 | $21.31B | 41.4% | $3.51B | $1.41B | $15.49 | — |
| Q3 2025 | $5.29B | 58.3% | $889.0M | $342.0M | $3.86 | — |
| Q2 2025 | $5.27B | 82.3% | $823.0M | $288.0M | $3.14 | — |
| Q1 2025 | $5.22B | 42.0% | $943.0M | $406.0M | $4.27 | — |
| Q4 2024 | $5.07B | 40.3% | $821.0M | $318.0M | $3.32 | — |
| FY 2024 | $20.66B | 39.7% | $5.96B | $3.20B | $32.70 | — |
| Q3 2024 | $5.12B | 39.5% | $1.09B | $472.0M | $4.89 | — |
| Q2 2024 | $5.10B | 39.7% | $761.0M | $259.0M | $2.64 | — |
| Q1 2024 | $5.37B | 39.4% | $3.29B | $2.15B | $21.38 | — |
| Q4 2023 | $5.38B | 39.6% | $735.0M | $244.0M | $2.30 | — |
| FY 2023 | $20.55B | 38.0% | $2.51B | $611.0M | $5.71 | — |